Yes, cannabis affects everyone differently, and the reasons go far beyond simple tolerance. Your genetics, body composition, sex, age, mood, and even the specific product you use all shape whether you feel relaxed, anxious, euphoric, or barely anything at all. Two people can take the same dose from the same product and have completely different experiences. Here’s why.
Your Liver Enzymes Control How Fast You Process THC
One of the biggest reasons for individual variation is how quickly your liver breaks down THC. A single enzyme family handles roughly 70% of THC clearance from your body. But not everyone produces these enzymes at the same rate. People who carry certain genetic variants of the CYP2C9 enzyme retain only about 7% of normal enzyme activity. After eating an edible, these slow metabolizers end up with three times the THC exposure in their bloodstream compared to fast metabolizers taking the exact same dose.
This matters most with edibles, where THC passes through the liver before reaching the brain. If you’ve ever watched a friend eat half a gummy and get floored while you barely felt it (or vice versa), liver enzyme variation is a likely explanation. There’s no consumer test for this, but it’s worth knowing that “start low and go slow” advice exists partly because of this invisible metabolic lottery.
Body Fat Changes How Long THC Sticks Around
THC is highly fat-soluble, meaning it gets rapidly absorbed into fatty tissue throughout your body. From those fat deposits, it slowly releases back into the bloodstream over time. This is why the half-life of THC varies so dramatically between people: occasional users clear it in roughly 1 to 3 days, while chronic users may take 5 to 13 days. People with more body fat have more storage capacity for THC, which can extend how long traces remain in their system and influence the tail end of a high.
Biological Sex Shapes the Response
Men and women differ in both their baseline receptor systems and how hormones modulate the cannabis experience. Brain imaging studies show that men have, on average, 41% more cannabinoid receptors (the docking sites where THC acts) than women, with the largest differences concentrated in brain regions involved in memory and self-awareness.
Estrogen plays a complex role. It lowers cannabinoid receptor density in some brain areas, like the hypothalamus and hippocampus, while increasing it in others, like the amygdala, which processes emotions and fear. Cannabinoid receptor levels in women also fluctuate across the menstrual cycle as estrogen rises and falls. This means the same woman may respond somewhat differently to the same dose depending on where she is in her cycle. Animal research confirms that many cannabinoid responses, including pain relief and sensitivity to THC’s effects, depend on circulating estrogen levels.
Younger Brains React Differently
The brain continues developing well into the mid-20s, and cannabis interacts with a still-maturing system differently than a fully developed one. In adults, cognitive effects like reduced attention, slower processing speed, and memory disruption tend to be mild and largely reversible after a period of abstinence. In adolescents, the picture is more concerning. The brain regions responsible for memory, decision-making, and impulse control are still under construction during the teenage years, and regular cannabis use during this window carries a higher risk of lasting effects on those functions. This doesn’t mean every teenager who tries cannabis will experience harm, but the developing brain is measurably more vulnerable.
Tolerance Builds Fast and Resets Slowly
If you use cannabis regularly, your brain physically adapts by pulling cannabinoid receptors off the surface of neurons, a process called downregulation. This is why daily users need more to feel the same effects. Brain imaging studies of chronic daily smokers confirmed that receptor density drops significantly with regular use.
The good news is that this process reverses. After about four weeks of abstinence, cannabinoid receptor levels return to normal in most brain regions. This is why tolerance breaks work, and why returning to cannabis after a break often produces a noticeably stronger effect at the same dose you were previously using. The timeline matters: partial recovery happens within two weeks, but full normalization typically takes closer to a month.
Low Doses and High Doses Can Do Opposite Things
Cannabis has what researchers call a biphasic effect, meaning low and high doses can produce opposite responses. This is especially well-documented with anxiety. At low doses, cannabinoids tend to reduce anxiety by acting on one set of brain circuits. At higher doses, they activate a different set of circuits and can trigger significant anxiety or paranoia instead. The mechanism involves two different types of nerve cells: at low doses, cannabinoids calm excitatory signaling, producing relaxation. At high doses, they suppress the brain’s own calming signals, which can tip the balance toward anxious, racing thoughts.
This is why someone who feels great after one hit might feel terrible after three. It’s not just “more of the same,” it’s a qualitatively different neurological event. Your personal threshold between the calming and anxious zones depends on all the factors above: your receptor density, your metabolism, your tolerance, and your current mental state.
Your Mindset and Environment Matter
The concept of “set and setting,” your psychological mindset and your physical surroundings, significantly influences the cannabis experience. Going in anxious or stressed increases the likelihood of an unpleasant high. Being in an unfamiliar or uncomfortable environment does the same. Conversely, feeling relaxed, being in a familiar space, and having a positive intention going into the experience are all associated with better outcomes. Calming lighting, comfortable surroundings, and feeling socially safe aren’t just nice extras. They actively shape the neurochemical experience by reducing the baseline anxiety that cannabinoids can amplify at higher doses.
The Plant Itself Varies Enormously
Beyond human biology, the cannabis product itself introduces another layer of variability. Different strains contain distinct ratios of cannabinoids and terpenes, the aromatic compounds that give each strain its smell. These terpenes aren’t just flavoring. They have their own biological effects, including anti-inflammatory, anti-anxiety, and sedative properties. One strain’s terpene profile may reduce THC-induced anxiety while another’s may do nothing to buffer it. The interaction between a specific plant’s chemical profile and a specific person’s biology is unique every time, which is part of why strain recommendations from friends are unreliable. What works for someone else’s brain chemistry and receptor landscape may not work for yours.
Genetics Are Real but Complicated
You may have heard that specific genes like AKT1 or COMT determine your risk of cannabis-induced psychosis or paranoia. Early studies suggested these genes played a strong role, but larger, more rigorous research has complicated that picture. A study of 720 participants, including people with psychotic disorders and healthy cannabis users, found that variations in the most commonly cited genes (AKT1, COMT, and FAAH) did not predict who experienced psychotic-like symptoms or euphoria from cannabis. Genetics almost certainly play a role in cannabis sensitivity, but it likely involves many genes with small individual effects rather than a few genes with large, predictable impacts.
What genetics clearly do influence is the metabolic side. The CYP2C9 enzyme variations that control THC breakdown are well-established and have large, measurable effects on how much THC reaches your brain. So your genes matter, just not always in the ways popular science coverage suggests.